Risorse esterne
Opinione della community
Prezzo Variazione Volume
1.7493 +0.0693 €
P/E Obiettivo ad 1anno
0 7 €

Compra - Vendi

Tutte le tue transazioni per questo titolo

Devi effettuare l'accesso


Altri utenti che hanno investito

Transations in last week
Buy: 21
Sell : 8

Matteo Berci Federico Borghi edoardo Simone Bonzanini LucaMazzu91



Can-Fite BioPharma (CANF) Receives $500K Milestone Payment From CKD Pharmaceuticals -

Can-Fite BioPharma Ltd. (NYSE: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today announced it has received a milestone payment in the ...altro » Leggi

Pluristem raises $15m, Can-Fite raises $5m - Globes

Two biomed companies, Pluristem Therapeutics Ltd. (Nasdaq:PSTI; TASE: PLTR) and Can-Fite BioPharma Ltd. (TASE:CFBI), announced financing rounds at the end of last week. Pluristem raised $15 million, after enlarging its planned offering, while Can-Fite ...altro » Leggi

1.72 - MarketWatch

Can-Fite Biopharma Ltd. ADR. Watchlist CreateCANFAlert. Open. Last Updated: Sep 22, 2017 2:28 p.m. EDT Delayed quote .... Can-Fite Bio awarded patent covering ED candidate. Nov. 9, 2016 at 7:38 a.m. ET; on Seeking Alpha. Sponsored .... and current end ... Leggi

Pipeline Insights on Nonalcoholic Steatohepatitis Market - MarketWatch

... Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Can-Fite BioPharma Ltd., Cardax Pharmaceuticals, Inc., Catabasis Pharmaceuticals, Inc., Cerenis Therapeutics Holding SA, Conatus Pharmaceuticals Inc., Connexios Life Sciences Pvt. Ltd.altro » Leggi

The Plaque Psoriasis (Psoriasis Vulgaris) Pipeline 2016 Market Report - MarketWatch

... Avexxin AS, BIOCAD, Biocon Limited, Bionovis SA, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Can-Fite BioPharma Ltd., Celgene Corporation, Cellceutix Corporation, Celltrion, Inc., Clonz Biotech Private Limited, Coherus BioSciences, ...altro » Leggi

Pipeline of Psoriasis Market Covering 140 Companies Reviewed for H1 2016 - MarketWatch

Companies discussed in this Psoriasis Pipeline Review, H1 2016 report include 3SBio Inc., 4SC AG, Abeome Corporation, AbGenomics International, Inc., ADC Therapeutics Sarl, Addex Therapeutics Ltd, Advinus Therapeutics Ltd., Affibody AB, Ajinomoto ...altro » Leggi

Zacks Initiates on Pulmatrix (NASDAQ:PULM) - Zacks Small Cap Research (press release)

Lactose blends have limited delivery efficiency, are flow rate dependent, and can cause significant side effects based on high throat deposition (i.e. much of the drug deposited in the throat instead of the lungs). ..... In early 2016 a marketing study ...altro » Leggi

Analysts: Small-Cap Biotech Stocks Investors Need to Know Now -

Ganetespib, in combination with other drugs, is also being evaluated in a number of investigator-sponsored trials for breast cancer, rectal carcinoma, recurring ovarian cancer and mesothelioma. "These are all Phase 1 and .... Hazlett's second small-cap ... Leggi

RepliCel (RP.V) Should Benefit From Renewed Investor Focus, Sweeping Legislation On Cell Therapy - Zacks Small Cap Research (press release)

The combination of renewed investor attention and sweeping legislation should make it a good year for many publicly-traded regenerative medicine companies. One such company that looks very well-positioned to benefit from the ... In Japan, biopharma ...altro » Leggi

Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2016-2026 - MarketWatch

What can be expected from the ophthalmic drugs market [ ]? Which companies are going to be most successful in the next 10 years? Which therapeutic areas are going to grow at the fastest rates? This visiongain ...altro » Leggi